1 year return (CAGR)
-73.11%
Anavex Life Sciences Corp Exchange (NASDAQ, USD)
AVXL
2.38
-0.05 (-2.08%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-30.92%
5 year return (CAGR)
-32.74%
10 year return (CAGR)
-0.93%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
217.84M
Price/Sales
-
Ent value
107.20M
Price/Book
1.94
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
3.79%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 2.47 |
| Daily high | 2.48 |
| Daily low | 2.31 |
| Daily Volume | 767K |
| All-time high | 28.86 |
| 1y analyst estimate | 20.00 |
| Beta | 1.14 |
| EPS (TTM) | -0.26 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 7 May 2026 |
Downside potential
Loading...
Downside potential data
| AVXL | S&P500 | |
| Current price drop from All-time high | -91.75% | -0.84% |
| Highest price drop | -97.06% | -56.47% |
| Date of highest drop | 19 Nov 2014 | 9 Mar 2009 |
| Avg drop from high | -67.13% | -10.68% |
| Avg time to new high | 44 days | 12 days |
| Max time to new high | 3301 days | 1805 days |
News
